Sex differences in adverse events from systemic treatments for psoriasis: A decade of insights from the Swiss Psoriasis Registry (SDNTT).
Fabio VerardiLara Valeska MaulKim BorskySimona SteinmannNina RossetHector Ortega PonsChristina SorbeNikhil YawalkarRaphael MicheroliAlexander EgebergJacob P ThyssenKristine HeidemeyerWolf-Henning BoehnckeCurdin ConradAntonio CozzioAndreas PinterThomas KündigAlexander A NavariniJulia-Tatjana MaulPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Females were associated with a significantly higher rate of ADRs and drug-related discontinuation rates. Sex stratification should be taken into consideration when designing studies in the patient-tailored management of psoriasis.